Literature DB >> 25957583

Transdifferentiation of Bone Marrow Mesenchymal Stem Cells into the Islet-Like Cells: the Role of Extracellular Matrix Proteins.

Marta Pokrywczynska1, Marzena Anna Lewandowska2,3, Sandra Krzyzanowska4, Arkadiusz Jundzill4, Marta Rasmus4, Karolina Warda4, Maciej Gagat5, Aleksander Deptula6, Anna Helmin-Basa7, Marcin Holysz8, Maciej Nowacki4, Lukasz Buchholz4, Magdalena Bodnar9, Andrzej Marszalek9,10, Alina Grzanka5, Wojciech Jozwicki11, Jacek Michalkiewicz7, Tomasz Drewa4,12.   

Abstract

Pancreatic islet implantation has been recently shown to be an efficient method of treatment for type 1 diabetes. However, limited availability of donor islets reduces its use. Bone morrow would provide potentially unlimited source of stem cells for generation of insulin-producing cells. This study was performed to evaluate the influence of extracellular matrix proteins like collagen, laminin, and vitronectin on bone marrow mesenchymal stem cells (BM-MSCs) transdifferentiation into islet-like cells (ILCs) in vitro. To our knowledge, this is the first report evaluating the importance of vitronectin in transdifferentiation of BM-MSCs into ILCs. Rat BM-MSCs were induced to ILCs using four-step protocol on plates coated with collagen type IV, laminin type I and vitronectin type I. Quantitative real-time PCR was performed to detect gene expression related to pancreatic β cell development. The induced cells expressed islet-related genes including: neurogenin 3, neurogenic differentiation 1, paired box 4, NK homeobox factor 6.1, glucagon, insulin 1 and insulin 2. Laminin but not collagen type IV or vitronectin enhanced expression of insulin and promoted formation of islet-like structures in monolayer culture. Laminin triggered transdifferentiation of BM-MSCs into ILCs.

Entities:  

Keywords:  Collagen; Islet-like cells; Laminin; Mesenchymal stem cells; Transdifferentiation; Vitronectin

Mesh:

Substances:

Year:  2015        PMID: 25957583     DOI: 10.1007/s00005-015-0340-3

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  6 in total

1.  Cell sheet biofabrication by co-administration of mesenchymal stem cells secretome and vitamin C on thermoresponsive polymer.

Authors:  Behnaz Banimohammad Shotorbani; Helder André; Abolfazl Barzegar; Nosratollah Zarghami; Roya Salehi; Effat Alizadeh
Journal:  J Mater Sci Mater Med       Date:  2018-11-03       Impact factor: 3.896

2.  Adult Stem Cells and Diabetes Therapy.

Authors:  Handenur Ilgun; Joseph William Kim; LuGuang Luo
Journal:  J Stem Cell Res Transplant       Date:  2015-12-31

Review 3.  Current progress in stem cell therapy for type 1 diabetes mellitus.

Authors:  Shuai Chen; Kechen Du; Chunlin Zou
Journal:  Stem Cell Res Ther       Date:  2020-07-08       Impact factor: 6.832

Review 4.  Signaling Molecules Regulating Pancreatic Endocrine Development from Pluripotent Stem Cell Differentiation.

Authors:  Hui Huang; Taylor N Bader; Sha Jin
Journal:  Int J Mol Sci       Date:  2020-08-15       Impact factor: 5.923

Review 5.  From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Progress and Challenges.

Authors:  Mohamed A Ghoneim; Ayman F Refaie; Batoul L Elbassiouny; Mahmoud M Gabr; Mahmoud M Zakaria
Journal:  Stem Cell Rev Rep       Date:  2020-12       Impact factor: 5.739

6.  Melatonin Pretreatment Enhances the Homing of Bone Marrow-derived Mesenchymal Stem Cells Following Transplantation in a Rat Model of Liver Fibrosis.

Authors:  Keywan Mortezaee; Parichehr Pasbakhsh; Iraj Ragerdi Kashani; Fatemeh Sabbaghziarani; Ameneh Omidi; Adib Zendedel; Soudabeh Ghasemi; Ahmad Reza Dehpour
Journal:  Iran Biomed J       Date:  2016-04-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.